宗教性 OCD に対する受容とコミットメントの療法
宗教的指向性強迫性障害に対する受容およびコミットメント療法の有効性
The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:David Johnson
- 電話番号:8013891733
- メール:dajohns4@uab.edu
研究連絡先のバックアップ
- 名前:Nicholas Borgogna, PhD
- 電話番号:7579693677
- メール:borgogna@uab.edu
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35233
- 募集
- University of Alabama at Birmingham
-
コンタクト:
- David Johnson, MA
- 電話番号:(205) 547-9502
- メール:dajohns4@uab.edu
-
コンタクト:
- Nicholas Borgogna, PhD
- メール:borgogna@uab.edu
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 18 years old
- Meet cutoff scores for scrupulosity
Exclusion Criteria:
- Presence of psychotic symptoms within six months of screening
- Current suicidal/homicidal plan/intent and/or a suicide/homicide attempt within 6 months of screening
- Non-suicidal self-injury within 6 months of screening
- Narcotics use within 3 months of screening
- Purging/restricting behavior within 3 months of screening.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Acceptance and Commitment Therapy
Participants will receive twelve consecutive weeks of acceptance and commitment therapy |
participants will then receive ACT-based individual therapy weekly for twelve weeks. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Scrupulosity Obsessions and Compulsions Scale
時間枠:At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
|
The Scrupulosity Obsessions and Compulsions Scale (SOCS) is a 10-item scale that asks participants how often they experience religious OCD obsessions and compulsions. The questions are asked on a scale ranging from 0 (Very Rarely) to 5 (Very Often). |
At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
|
|
Experiential Avoidance Rating Scale
時間枠:At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
|
The Experiential Avoidance Rating Scale (EARS) is a 6-item scale that asks participants how true statements about avoiding experiences are for them. The questions are asked on a scale ranging from 1 (Never True) to 5 (Very Often True). |
At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Centrality of Religiosity Scale - Interreligious 20
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Centrality of Religiosity Scale - Interreligious 20 (CRSi-20) is a 20-item scale assessing religiosity across 5 dimensions (Intellect, Ideology, Public practice, Private practice, Experience). The questions are asked on scales ranging from Never to Several times a day, Never to Very often, and Not at all to Very much so. |
Pre and post intervention which in general lasts 12 weeks
|
|
Yale-Brown Obsessive and Compulsive Scale - Self Report
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Yale-Brown Obsessive and Compulsive Scale (Y-BOCS) is a 12-item scale that asks participants whether they experience various OCD obsessions and compulsions. Participants are then asked how much time is spent on these obsessions and compulsions, whether they give in to the urge to perform compulsions, how strong the drive is to give in to compulsions, how they would feel if they were prevented from engaging in compulsions, and how much the compulsions and avoidance of compulsions interfere with their functioning. |
Pre and post intervention which in general lasts 12 weeks
|
|
Patient Health Questionnaire - 9
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Patient Health Questionnaire (PHQ-9) is a 9-item scale that asks participants how often they have been bothered by aspects of depressive symptoms. The questions are asked on a scale ranging from 0 (Not at all) to 5 (Nearly every day). |
Pre and post intervention which in general lasts 12 weeks
|
|
Generalized Anxiety Disorder - 7
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Generalized Anxiety Disorder Scale (GAD-7) is a 7-item scale that asks participants how often they have been bothered by statements capturing aspects of anxiety. The questions are asked on a scale ranging from 0 (Not at all) to 3 (Nearly every day). |
Pre and post intervention which in general lasts 12 weeks
|
|
The Intrinsic Spirituality Scale
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Intrinsic Spirituality Scale is a 6-item scale that asks participants about aspects of their spirituality. |
Pre and post intervention which in general lasts 12 weeks
|
|
Psy-Flex
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Psyflex questionnaire is a 6-item scale that measures aspects of psychological flexibility. The questions are asked on a scale ranging from very seldom to often. |
Pre and post intervention which in general lasts 12 weeks
|
|
Almost Perfect Scale - Revised
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Almost Perfect Scale - Revised is a 23-item scale that asks participants their agreement on items capturing perfectionism. The questions are asked on a scale ranging from 1 (Strongly disagree) to 7 (Strongly agree). |
Pre and post intervention which in general lasts 12 weeks
|
|
The Alcohol Use Disorders Identification Test
時間枠:Pre and post intervention which in general lasts 12 weeks
|
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item scale that asks participants about their alcohol consumption. |
Pre and post intervention which in general lasts 12 weeks
|
|
National Institute on Drug Abuse Screener
時間枠:Pre and post intervention which in general lasts 12 weeks
|
National Institute on Drug Abuse Screener (NIDA) is a 1-item scale that asks participants how often they use a variety of substances. The questions are asked on a scale ranging from Never to Daily or Almost Daily. |
Pre and post intervention which in general lasts 12 weeks
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- IRB-300013565-001
- UAB (その他の識別子:UAB)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。